1
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Enhanced proteolysis of IκBα and IκBβ proteins in astrocytes by Moloney murine leukemia virus (MoMuLV)- ts 1 infection: A potential mechanism of NF-κB activation

Pages 466-475 | Published online: 10 Jul 2009
 

Abstract

Moloney murine leukemia virus (MoMuLV)- ts 1-mediated neuronal degeneration in mice is likely due to loss of glial support and release of inflammatory cytokines and neurotoxins from surrounding ts 1-infected glial cells including astrocytes. NF- &#115 B is a transcription factor that participates in the transcriptional activation of a variety of immune and inflammatory genes. We investigated whether ts 1 activates NF- &#115 B in astrocytes and examined the mechanism(s) responsible for the activation of NF- &#115 B by ts 1 infection in vitro . Here we present evidence that ts 1 infection of astrocytes in vitro activates NF- &#115 B by enhanced proteolysis of the NF- &#115 B inhibitors, I &#115 B &#102 and I &#115 B &#103 . In in vitro studies using protease inhibitors, I &#115 B &#102 proteolysis in ts 1-infected astrocytes was significantly blocked by a specific calpain inhibitor calpeptin but not by MG-132, a specific proteasome inhibitor, whereas rapid I &#115 B &#103 proteolysis was blocked by MG-132. Furthermore, treatment with MG-132 increased levels of multiubiquitinated I &#115 B &#103 protein in ts 1-infected astrocytes. These results indicate that the calpain proteolysis is a major mechanism of I &#115 B &#102 proteolysis in ts 1-infected astrocytes. Additionally, ts 1 infection of astrocytes in vitro increased expression of inducible nitric oxide synthase (iNOS), a NF- &#115 B-dependent gene product. Our results suggest that NF- &#115 B activation in ts 1-infected astrocytes is mediated by enhanced proteolysis of I &#115 B &#102 and I &#115 B &#103 through two different proteolytic pathways, the calpain and ubiquitin-proteasome pathways, resulting in increased expression of iNOS, a NF- &#115 B-dependent gene.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.